-
1
Oral probiotic extracellular vesicle therapy mitigates Influenza A Virus infection via blunting IL-17 signaling
Published 2025-03-01Subjects: Get full text
Article -
2
The case for development of a core outcome set (COS) and supplemental reporting guidelines for influenza vaccine challenge trial research in swine
Published 2025-02-01Subjects: Get full text
Article